SCA
PMC

STALEY CAPITAL ADVISERS’s PharMerica Corporation PMC Stock Holding History

STALEY CAPITAL ADVISERS’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-24,753
Closed -$725K – 170
2017
Q3 		$725K Buy
24,753
+5,167
+26% +$145K 0.06% 93
2017
Q2 		$514K Hold
19,586
– – 0.04% 103
2017
Q1 		$458K Hold
19,586
– – 0.04% 91
2016
Q4 		$493K Hold
19,586
– – 0.05% 82
2016
Q3 		$550K Buy
19,586
+5,121
+35% +$131K 0.05% 75
2016
Q2 		$357K Hold
14,465
– – 0.04% 92
2016
Q1 		$320K Hold
14,465
– – 0.03% 92
2015
Q4 		$506K Hold
14,465
– – 0.06% 78
2015
Q3 		$412K Hold
14,465
– – 0.05% 86
2015
Q2 		$482K Buy
14,465
+2,909
+25% +$89.3K 0.05% 82
2015
Q1 		$326K Hold
11,556
– – 0.04% 95
2014
Q4 		$239K Hold
11,556
– – 0.03% 109
2014
Q3 		$282K Buy
+11,556
New +$306K 0.03% 103

STALEY CAPITAL ADVISERS's PMC Position: Q4 2017 in Review

STALEY CAPITAL ADVISERS sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 24,753 shares — an estimated $725K sold.

STALEY CAPITAL ADVISERS first reported a position in PMC in Q3 2014 and held it in 13 quarters. The position peaked at $725K in Q3 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.

  • STALEY CAPITAL ADVISERS reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
  • STALEY CAPITAL ADVISERS sold 24,753 PharMerica Corporation shares in Q4 2017, an estimated $725K.
  • STALEY CAPITAL ADVISERS first reported a position in PharMerica Corporation in Q3 2014 and held it in 13 quarters.
  • STALEY CAPITAL ADVISERS's PharMerica Corporation position peaked at $725K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.

Based on STALEY CAPITAL ADVISERS's 13F filing for Q4 2017, filed 12 Feb 2018.